181 related articles for article (PubMed ID: 20371960)
1. Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor.
Kosugi N; Tsurutani Y; Isonishi A; Hori Y; Matsumoto M; Fujimura Y
Intern Med; 2010; 49(7):689-93. PubMed ID: 20371960
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.
Thomas MR; de Groot R; Scully MA; Crawley JT
EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702
[TBL] [Abstract][Full Text] [Related]
3. A 35-year-old woman with influenza A-associated thrombotic thrombocytopenic purpura.
Jonsson MK; Hammenfors D; Oppegaard O; Bruserud Ø; Kittang AO
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):469-72. PubMed ID: 25688460
[TBL] [Abstract][Full Text] [Related]
4. Acquired Thrombotic Thrombocytopenic Purpura Without Anti-ADAMTS13 Antibody Caused by Influenza A (H1N1) Virus Successfully Treated by Plasma Exchange: A Case Report.
Kubo K; Abe T; Kawano N; Ochiai H
Am J Case Rep; 2021 Aug; 22():e932251. PubMed ID: 34334786
[TBL] [Abstract][Full Text] [Related]
5. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
6. A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13.
Sato A; Hoshi Y; Onuma M; Sato R; Tsunematsu Y; Isonishi A; Matsumoto M; Fujimura Y; Imaizumi M
Pediatr Hematol Oncol; 2010 Feb; 27(1):53-8. PubMed ID: 20121555
[TBL] [Abstract][Full Text] [Related]
7. ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
Tsai HM; Raoufi M; Zhou W; Guinto E; Grafos N; Ranzurmal S; Greenfield RS; Rand JH
Thromb Haemost; 2006 May; 95(5):886-92. PubMed ID: 16676082
[TBL] [Abstract][Full Text] [Related]
8. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.
Ferrari S; Palavra K; Gruber B; Kremer Hovinga JA; Knöbl P; Caron C; Cromwell C; Aledort L; Plaimauer B; Turecek PL; Rottensteiner H; Scheiflinger F
Haematologica; 2014 Apr; 99(4):779-87. PubMed ID: 24241492
[TBL] [Abstract][Full Text] [Related]
9. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.
Ferrari S; Mudde GC; Rieger M; Veyradier A; Kremer Hovinga JA; Scheiflinger F
J Thromb Haemost; 2009 Oct; 7(10):1703-10. PubMed ID: 19682238
[TBL] [Abstract][Full Text] [Related]
10. Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
Yamaguchi Y; Moriki T; Igari A; Nakagawa T; Wada H; Matsumoto M; Fujimura Y; Murata M
Thromb Res; 2011 Aug; 128(2):169-73. PubMed ID: 21496883
[TBL] [Abstract][Full Text] [Related]
11. Sepsis-induced disseminated intravascular coagulation with features of thrombotic thrombocytopenic purpura: a fatal fulminant syndrome.
Wang Z; Yu Z; Su J; Cao L; Zhao X; Ruan C
Clin Appl Thromb Hemost; 2011 Jun; 17(3):251-3. PubMed ID: 20211920
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
[TBL] [Abstract][Full Text] [Related]
13. Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura.
Grillberger R; Casina VC; Turecek PL; Zheng XL; Rottensteiner H; Scheiflinger F
Haematologica; 2014 Apr; 99(4):e58-60. PubMed ID: 24532042
[No Abstract] [Full Text] [Related]
14. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
Starke R; Machin S; Scully M; Purdy G; Mackie I
Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
[TBL] [Abstract][Full Text] [Related]
15. Evolution of ADAMTS13 antibodies in a fatal case of thrombotic thrombocytopenic purpura.
Dong L; Chandrasekaran V; Zhou W; Tsai HM
Am J Hematol; 2008 Oct; 83(10):815-7. PubMed ID: 18661493
[TBL] [Abstract][Full Text] [Related]
16. The significance of ADAMTS13 in a patient with thrombotic thrombocytopenic purpura complicated autoimmune hepatitis.
Shimizu M; Nomura S; Ishii K; Mohri Y; Umei N; Suzuki S; Matsuo Y; Isonishi A; Matsumoto M; Urase F; Maeda Y; Fujimura Y
Thromb Haemost; 2009 Mar; 101(3):599-600. PubMed ID: 19277430
[No Abstract] [Full Text] [Related]
17. Thrombotic thrombocytopenic purpura complicated with hypereosinophilic syndrome.
Ohguchi H; Sugawara T; Harigae H
Intern Med; 2009; 48(18):1687-90. PubMed ID: 19755775
[TBL] [Abstract][Full Text] [Related]
18. Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura.
Tersteeg C; Schiviz A; De Meyer SF; Plaimauer B; Scheiflinger F; Rottensteiner H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2336-42. PubMed ID: 26338302
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic thrombocytopenic purpura associated with statin therapy.
Thomas MR; McDonald V; Machin SJ; Scully MA
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):762-3. PubMed ID: 22198366
[No Abstract] [Full Text] [Related]
20. Value of ADAMTS13 activity and inhibitor in the postmortem diagnosis of thrombotic thrombocytopenic purpura.
Dwyre DM; Dursteler B; Nashelsky M; Friedman KD; Raife TJ
J Clin Apher; 2009; 24(3):106-10. PubMed ID: 19253359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
